NanoViricides Inc. (NNVC)

[arvitar]

" FY2017 GOALS ACCOMPLISHED


We have ended FY2017 reaching close to completing optimization of our Shingles drug candidate, and getting ready to designate the clinical drug candidate, which will go into Tox-­Package studies and human clinical trials. We have begun optimization of the HSV-2 “genital ulcers” topical treatment. We have focused on large scale process implementation and quality assurance characterization development for the HerpeCide drug candidates. We have begun implementing muli-­-kg-­-scale production for the shingles drug candidate in a cGMP-­-like fashion, suitable for Tox Package & Phase I clinical studies" p.4


^Is this poorly written summary of all their major accomplishments not useful?

It shows prospective investors that these people don't distinguish between "goals accomplished" and things that they are "reaching close to completing", "getting ready for", or that they "have begun".

It also shows that everything they claimed to be "close to completing" and "getting ready for" a year ago remain undone a year later.

Finally, it shows the lack honesty and basic disregard for the intelligence of others, by claiming to have been doing a bunch of things in year 2017 for a lead candidate that they still have not even identified a year later.